The influence of North American Aboriginal ethnicity on pro-inflammatory and anti-inflammatory cytokine responses to IFN-alpha

Journal of Viral Hepatitis

Volumn 16, Issue 4, 2009, Pages 292-297

  Rempel, J D ^a   Aborsangaya, K B ^a   Alphonse, M P ^a   Minuk, G Y ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

HCV; IFN induced cytokine responses; North American Aboriginal ethnicity

Indexed keywords

ALPHA INTERFERON; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; STAT3 PROTEIN; VIRUS PROTEIN;

ABORIGINE; ADULT; ARTICLE; CAUCASIAN; CELL CULTURE; COHORT ANALYSIS; CYTOKINE PRODUCTION; ETHNICITY; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNE SYSTEM; NORTH AMERICA; PERIPHERAL BLOOD MONONUCLEAR CELL; POPULATION; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN SYNTHESIS; REOVIRUS; SUPERNATANT; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CELL NUCLEUS; CYTOKINES; CYTOPLASM; ETHNIC GROUPS; HEPACIVIRUS; HUMANS; INTERFERON-ALPHA; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; REOVIRIDAE; STAT3 TRANSCRIPTION FACTOR; YOUNG ADULT;

EID: 61449225716     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2008.01063.x     Document Type: Article

References (33)

1. Alter M.J, Kruszon-Moran D, Nainan OV et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999 341 : 556 562.
2. Cerny A, Chisari FV. Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. Hepatology 1999 30 : 595 601.
3. Samuel CE. Antiviral actions of interferons. Clin Microbiol Rev 2001 14 : 778 809 (table of contents).
4. Biron CA. Role of early cytokines, including alpha and beta interferons (IFN-alpha/beta), in innate and adaptive immune responses to viral infections. Semin Immunol 1998 10 : 383 390.
5. Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 2001 194 : 1395 1406.
6. Antonaci S, Piazzolla G, Napoli N, Vella FS, Fiore G, Schiraldi O. Relationship between T lymphocyte responsiveness and T-helper1/T-helper2 type cytokine release in chronic hepatitis C: a critical reappraisal. Microbios 2001 106 : 203 212.
7. Piazzolla G, Tortorella C, Schiraldi O, Antonaci S. Relationship between interferon-gamma, interleukin-10, and interleukin-12 production in chronic hepatitis C and in vitro effects of interferon-alpha. J Clin Immunol 2000 20 : 54 61.
8. Kimball P, Elswick RK, Shiffman M. Ethnicity and cytokine production gauge response of patients with hepatitis C to interferon-alpha therapy. J Med Virol 2001 65 : 510 516.
9. Delpuech O, Buffello-Le Guillou DB, Rubinstein E, Feray C, Petit MA. The hepatitis C virus (HCV) induces a long-term increase in interleukin-10 production by human CD4+ T cells (H9). Eur Cytokine Netw 2001 12 : 69 77.
10. Woitas RP, Petersen U, Moshage D et al. HCV-specific cytokine induction in monocytes of patients with different outcomes of hepatitis C. World J Gastroenterol 2002 8 : 562 566.
11. Mangia A, Santoro R, Piattelli M et al. IL-10 haplotypes as possible predictors of spontaneous clearance of HCV infection. Cytokine 2004 25 : 103 109.
12. Knapp S, Hennig BJ, Frodsham AJ et al. Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection. Immunogenetics 2003 55 : 362 369.
13. Luik A, Knapp S, Thursz M, Thomas HC, Schlaak JF. Autoregulatory role of interleukin-10 in hepatitis C patients treated with IFN-alpha. J Interferon Cytokine Res 2004 24 : 585 593.
14. Yee LJ, Tang J, Gibson AW, Kimberly R, Van Leeuwen DJ, Kaslow RA. Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection. Hepatology 2001 33 : 708 712.
15. Ziegler-Heitbrock L, Lotzerich M, Schaefer A, Werner T, Frankenberger M, Benkhart E. IFN-alpha induces the human IL-10 gene by recruiting both IFN regulatory factor 1 and Stat3. J Immunol 2003 171 : 285 290.
16. Larcombe L, Rempel JD, Dembinski I, Tinckam K, Rigatto C, Nickerson P. Differential cytokine genotype frequencies among Canadian Aboriginal and Caucasian populations. Genes Immun 2005 6 : 140 144.
17. Aborsangaya K, Dembinski I, Khatkar S, Alphonse M, Nickerson P, Rempel JD. The impact of Aboriginal ethnicity on HCV core induced IL-10 synthesis: interaction with IL-10 gene polymorphisms. Hepatology 2007 45 : 623 630.
18. Minuk GY, Zhang M, Wong SG et al. Viral hepatitis in a Canadian First Nations community. Can J Gastroenterol 2003 17 : 593 596.
19. Miller CL, Strathdee SA, Spittal PM et al. Elevated rates of HIV infection among young Aboriginal injection drug users in a Canadian setting. Harm Reduct J 2006 3 : 9 12.
20. National Association of Friendship Centers. Hepatitis C Information Manual. Available at: http://www.nafc-aboriginal.com/PDF/HepCManual.pdf 2004.
21. Wilson C. Hepatitis C infection and type 2 diabetes in American-Indian women. Diabetes Care 2004 27 : 2116 2119.
22. Minuk GY, Uhanova J. Viral hepatitis in the Canadian Inuit and First Nations populations. Can J Gastroenterol 2003 17 : 707 712.
23. Scott JD, McMahon BJ, Bruden D et al. High rate of spontaneous negativity for hepatitis C virus RNA after establishment of chronic infection in Alaska Natives. Clin Infect Dis 2006 42 : 945 952.
24. Grebely J, Raffa JD, Lai C, Krajden M, Conway B, Tyndall MW. Factors associated with spontaneous clearance of hepatitis C virus among illicit drug users. Can J Gastroenterol 2007 21 : 447 451.
25. Miller K, McArdle S, Gale MJ. Jr. et al. Effects of the hepatitis C virus core protein on innate cellular defense pathways. J Interferon Cytokine Res 2004 24 : 391 402.
26. Abramoff MD, Magelhaes PJ, Ram SJ. Image processing with ImageJ. Biophotonics Int 2004 11 : 34 42.
27. Samuel CE. Reoviruses and the interferon system. Curr Top Microbiol Immunol 1998 233 : 125 145.
28. Lechner F, Wong DK, Dunbar PR et al. Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 2000 191 : 1499 1512.
29. Yoshida T, Hanada T, Tokuhisa T et al. Activation of STAT3 by the hepatitis C virus core protein leads to cellular transformation. J Exp Med 2002 196 : 641 653.
30. Basu A, Meyer K, Lai KK et al. Microarray analyses and molecular profiling of Stat3 signaling pathway induced by hepatitis C virus core protein in human hepatocytes. Virology 2006 349 : 347 358.
31. Miyoshi H, Fujie H, Shintani Y et al. Hepatitis C virus core protein exerts an inhibitory effect on suppressor of cytokine signaling (SOCS)-1 gene expression. J Hepatol 2005 43 : 757 763.
32. Alonzi T, Maritano D, Gorgoni B, Rizzuto G, Libert C, Poli V. Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene inactivation in the liver. Mol Cell Biol 2001 21 : 1621 1632.
33. Ito S, Ansari P, Sakatsume M et al. Interleukin-10 inhibits expression of both interferon alpha- and interferon gamma-induced genes by suppressing tyrosine phosphorylation of STAT1. Blood 1999 93 : 1456 1463.